Komura Stephanie, Rodriguez Robert M, Peabody Christopher R
Department of Emergency Medicine, Zuckerberg San Francisco General Hospital, San Francisco, California.
Department of Emergency Medicine, Zuckerberg San Francisco General Hospital, San Francisco, California; Department of Emergency Medicine, University of California, San Francisco, California.
J Emerg Med. 2018 May;54(5):e97-e99. doi: 10.1016/j.jemermed.2018.01.029. Epub 2018 Mar 2.
Tranexamic acid (TXA) is a synthetic anti-fibrinolytic agent used to prevent and treat various bleeding complications. In many studies, investigators have evaluated its utility and safety orally, intravenously, and topically, but few studies have described the potential benefits of nebulized TXA.
We present a case of massive hemoptysis treated with nebulized TXA in the emergency department (ED) that led to the cessation of bleeding and avoidance of endotracheal intubation. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: In massive hemoptysis, rapidly available nebulized TXA may be considered a therapeutic option, serving either as primary therapy or as a bridge until other definitive therapies can be arranged.
氨甲环酸(TXA)是一种合成的抗纤溶药物,用于预防和治疗各种出血并发症。在许多研究中,研究人员评估了其口服、静脉注射和局部应用的效用和安全性,但很少有研究描述雾化吸入氨甲环酸的潜在益处。
我们报告1例在急诊科(ED)接受雾化吸入氨甲环酸治疗的大量咯血病例,该治疗使出血停止,并避免了气管插管。急诊医生为何应了解这一点?:在大量咯血时,可考虑将快速可用的雾化吸入氨甲环酸作为一种治疗选择,可作为主要治疗方法或作为一种过渡措施,直至能够安排其他确定性治疗。